CLINICAL TRIALS PROFILE FOR DICLEGIS
✉ Email this page to a colleague
All Clinical Trials for DICLEGIS
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT02045901 ↗ | A Multicenter Trial of the Efficacy and Safety of Diclegis® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents | Unknown status | Premier Research Group plc | Phase 4 | 2014-02-01 | The primary objective of this study is to compare the efficacy of Diclegis for the treatment of nausea and vomiting of pregnancy (NVP) in pregnant adolescents aged 12 to 17 years with placebo. The secondary objective of this study is to compare the safety of Diclegis in pregnant adolescents aged 12 to 17 years with placebo by assessing differences in the severity and occurrence of maternal adverse events (AEs). |
| NCT02045901 ↗ | A Multicenter Trial of the Efficacy and Safety of Diclegis® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents | Unknown status | Duchesnay Inc. | Phase 4 | 2014-02-01 | The primary objective of this study is to compare the efficacy of Diclegis for the treatment of nausea and vomiting of pregnancy (NVP) in pregnant adolescents aged 12 to 17 years with placebo. The secondary objective of this study is to compare the safety of Diclegis in pregnant adolescents aged 12 to 17 years with placebo by assessing differences in the severity and occurrence of maternal adverse events (AEs). |
| NCT03905564 ↗ | A Study to Investigate Differences in the Extent and Rate of Absorption of Doxylamine/Pyridoxine From 2 Different Products Under Fasting Conditions | Withdrawn | Grünenthal, S.A. | Phase 1 | 2019-06-01 | The purpose of the study is to investigate any difference in the extent and rate of absorption of doxylamine between the test (investigational medicinal product [IMP]) and reference products that could impact the bioavailability of the medication when administered under fasting conditions. |
| NCT03905564 ↗ | A Study to Investigate Differences in the Extent and Rate of Absorption of Doxylamine/Pyridoxine From 2 Different Products Under Fasting Conditions | Withdrawn | Grünenthal GmbH | Phase 1 | 2019-06-01 | The purpose of the study is to investigate any difference in the extent and rate of absorption of doxylamine between the test (investigational medicinal product [IMP]) and reference products that could impact the bioavailability of the medication when administered under fasting conditions. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DICLEGIS
Condition Name
Clinical Trial Locations for DICLEGIS
Trials by Country
Clinical Trial Progress for DICLEGIS
Clinical Trial Phase
Clinical Trial Sponsors for DICLEGIS
Sponsor Name
